AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced that William Heiden, AMAG’s chief executive officer, will participate in two investor conferences in September. The sessions will both be conducted in a question and answer format and will include a company overview and a review of the company’s growth opportunities. The sessions will take place as follows:
- September 5, at 1:55 p.m. ET – Baird’s 2012 Healthcare Conference in New York City; and
- September 10, at 11:45 a.m. ET – Morgan Stanley Global Healthcare Conference in New York City.